Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma

Completed · Phase 2

Conditions studied: Sarcoma

In brief

RATIONALE: Drugs used in chemotherapy, such as cytarabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well cytarabine works in treating young patients with recurrent or refractory Ewing's sarcoma.

Key facts

Study ID

NCT00470275

Run by

Children's Oncology Group

People needed

10

Starts

2007-05-01

Expected to finish

2013-12-01

Last updated by the study team

2014-10-20

Who can join

Age: any, up to 30. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Arizona Cancer Center at University of Arizona Health Sciences Center — Tucson, Arizona, United States
• Arkansas Cancer Research Center at University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
• Southern California Permanente Medical Group — Downey, California, United States
• Children's Hospital Central California — Madera, California, United States
• Children's Hospital of Orange County — Orange, California, United States
• UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California, United States
• Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center — Farmington, Connecticut, United States
• Lombardi Comprehensive Cancer Center at Georgetown University Medical Center — Washington D.C., District of Columbia, United States
• Lee Cancer Care of Lee Memorial Health System — Fort Myers, Florida, United States
• All Children's Hospital — St. Petersburg, Florida, United States
• St. Joseph's Cancer Institute at St. Joseph's Hospital — Tampa, Florida, United States
• Kaplan Cancer Center at St. Mary's Medical Center — West Palm Beach, Florida, United States
• Cancer Research Center of Hawaii — Honolulu, Hawaii, United States
• Children's Memorial Hospital - Chicago — Chicago, Illinois, United States
• Simmons Cooper Cancer Institute — Springfield, Illinois, United States
• Indiana University Melvin and Bren Simon Cancer Center — Indianapolis, Indiana, United States
• Lucille P. Markey Cancer Center at University of Kentucky — Lexington, Kentucky, United States
• Tulane Cancer Center Office of Clinical Research — Alexandria, Louisiana, United States
• Alvin and Lois Lapidus Cancer Institute at Sinai Hospital — Baltimore, Maryland, United States
• Massachusetts General Hospital — Boston, Massachusetts, United States
• Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute — Boston, Massachusetts, United States
• C.S. Mott Children's Hospital at University of Michigan Medical Center — Ann Arbor, Michigan, United States
• Hurley Medical Center — Flint, Michigan, United States
• Butterworth Hospital at Spectrum Health — Grand Rapids, Michigan, United States
• Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.